← Back to patent-cliff list
CAS 4594-52-9
(4S,5R)-5-(acetoxymethyl)tetrahydrofuran-2,4-diyl diacetate
Codes: DECI-015
Application context (from source-drug indications)
Allergic reactionDecitabineCycloplegiaDecitabineHypotensionDecitabineAcute myeloid leukaemiaDecitabineMyelodysplastic syndromeDecitabineDiffuse large B-cell lymphomaDecitabine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Decitabine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
N-(trimethylsilyl)-4-((trimethylsilyl)oxy)-1,3,5-triazin-2-amine→4-amino-1,3,5-triazin-2(1H)-one→trimethylsilyl (E)-N-(trimethylsilyl)acetimidate→(4S,5R)-5-(acetoxymethyl)tetrahydrofuran-2,4-diyl diacetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.